Cancer‑associated fibroblasts: a pivotal regulator of tumor microenvironment in the context of radiotherapy DOI Creative Commons

Linhui Zheng,

Wenqi Cai, Ke Yuan

и другие.

Cell Communication and Signaling, Год журнала: 2025, Номер 23(1)

Опубликована: Март 20, 2025

In the course of tumor treatment, radiation therapy (RT) not only kills cancer cells, but also induces complex biological effects in non-malignant cells around cells. These such as angiogenesis, changes stromal composition and immune cell infiltration remodel microenvironment (TME). As one major components TME, Cancer‑associated fibroblasts (CAFs) are involved tumorigenesis, progression, recurrence, metastasis regulate tumor-associated microenvironment. CAFs or have intercellular communication context radiation. Main content. Different cellular precursors, spatial location differences, absence specific markers, advances single-cell sequencing technology gradually made abundant heterogeneity well known. Due to unique radioresistance properties, can survive under high doses ionizing However, induce phenotypic functional further act on promote inhibit progression. To date, effect RT irradiated progression TME still defined. this review, we review origin, phenotypic, describe CAFs, focusing mutual crosstalk between after We discuss emerging strategies for targeted therapy.

Язык: Английский

Breast cancer: pathogenesis and treatments DOI Creative Commons
Xin Xiong,

Lewei Zheng,

Yu‐Qiang Ding

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2025, Номер 10(1)

Опубликована: Фев. 18, 2025

Abstract Breast cancer, characterized by unique epidemiological patterns and significant heterogeneity, remains one of the leading causes malignancy-related deaths in women. The increasingly nuanced molecular subtypes breast cancer have enhanced comprehension precision treatment this disease. mechanisms tumorigenesis progression been central to scientific research, with investigations spanning various perspectives such as tumor stemness, intra-tumoral microbiota, circadian rhythms. Technological advancements, particularly those integrated artificial intelligence, significantly improved accuracy detection diagnosis. emergence novel therapeutic concepts drugs represents a paradigm shift towards personalized medicine. Evidence suggests that optimal diagnosis models tailored individual patient risk expected are crucial, supporting era oncology for cancer. Despite rapid advancements increasing emphasis on clinical comprehensive update summary panoramic knowledge related disease needed. In review, we provide thorough overview global status including its epidemiology, factors, pathophysiology, subtyping. Additionally, elaborate latest research into contributing progression, emerging strategies, long-term management. This review offers valuable insights Cancer Research, thereby facilitating future progress both basic application.

Язык: Английский

Процитировано

27

CAF-induced physical constraints controlling T cell state and localization in solid tumours DOI
Ludovica Arpinati,

Giulia Carradori,

Ruth Scherz‐Shouval

и другие.

Nature reviews. Cancer, Год журнала: 2024, Номер 24(10), С. 676 - 693

Опубликована: Сен. 9, 2024

Язык: Английский

Процитировано

20

Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer DOI Creative Commons
Shan Liu,

Xingda Zhang,

Wenzheng Wang

и другие.

Molecular Cancer, Год журнала: 2024, Номер 23(1)

Опубликована: Ноя. 21, 2024

Metabolic alterations, a hallmark of cancer, enable tumor cells to adapt their environment by modulating glucose, lipid, and amino acid metabolism, which fuels rapid growth contributes treatment resistance. In primary breast metabolic shifts such as the Warburg effect enhanced lipid synthesis are closely linked chemotherapy failure. Similarly, metastatic lesions often display distinct profiles that not only sustain but also confer resistance targeted therapies immunotherapies. The review emphasizes two major aspects: mechanisms driving in both how unique environments sites further complicate treatment. By targeting vulnerabilities at stages, new strategies could improve efficacy existing provide better outcomes for cancer patients.

Язык: Английский

Процитировано

18

Energy metabolism in health and diseases DOI Creative Commons
Hui Liu, Shuo Wang, Jianhua Wang

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2025, Номер 10(1)

Опубликована: Фев. 18, 2025

Язык: Английский

Процитировано

15

Cancer associated fibroblasts in cancer development and therapy DOI Creative Commons

Hongyuan Jia,

Xingmin Chen,

Linling Zhang

и другие.

Journal of Hematology & Oncology, Год журнала: 2025, Номер 18(1)

Опубликована: Март 28, 2025

Cancer-associated fibroblasts (CAFs) are key players in cancer development and therapy, they exhibit multifaceted roles the tumor microenvironment (TME). From their diverse cellular origins, CAFs undergo phenotypic functional transformation upon interacting with cells presence can adversely influence treatment outcomes severity of cancer. Emerging evidence from single-cell RNA sequencing (scRNA-seq) studies have highlighted heterogeneity plasticity CAFs, subtypes identifiable through distinct gene expression profiles properties. multiple mechanisms, including regulation extracellular matrix (ECM) remodeling, direct promotion growth provision metabolic support, promoting epithelial-mesenchymal transition (EMT) to enhance invasiveness growth, as well stimulating stem cell properties within tumor. Moreover, induce an immunosuppressive TME contribute therapeutic resistance. In this review, we summarize fundamental knowledge recent advances regarding focusing on sophisticated potential targets. We discuss various strategies target ECM modulation, elimination, interruption CAF-TME crosstalk, CAF normalization, approaches developing more effective treatments. An improved understanding complex interplay between is crucial for new targeted therapies

Язык: Английский

Процитировано

4

Barriers and opportunities in pancreatic cancer immunotherapy DOI Creative Commons

Yixin Ju,

Dongzhi Xu,

Miao-Miao Liao

и другие.

npj Precision Oncology, Год журнала: 2024, Номер 8(1)

Опубликована: Сен. 12, 2024

Язык: Английский

Процитировано

17

Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications DOI Creative Commons
Xiaowen Xie, Weici Liu, Zhiyuan Yuan

и другие.

Molecular Cancer, Год журнала: 2025, Номер 24(1)

Опубликована: Март 8, 2025

Epigenomic modifications—such as DNA methylation, histone acetylation, and methylation—and their implications in tumorigenesis, progression, treatment have emerged a pivotal field cancer research. Tumors undergo metabolic reprogramming to sustain proliferation metastasis nutrient-deficient conditions, while suppressing anti-tumor immunity the tumor microenvironment (TME). Concurrently, immune cells within immunosuppressive TME adaptations, leading alterations function. The complicated interplay between metabolites epigenomic modulation has spotlighted significance of regulation immunometabolism. In this review, characteristics modification associated with tumors are systematically summarized alongside regulatory roles Classical emerging approaches delineated broaden boundaries research on crosstalk immunometabolism epigenomics. Furthermore, we discuss potential therapeutic strategies that target modulate modifications, highlighting burgeoning synergy therapies immunotherapy promising avenue for treatment.

Язык: Английский

Процитировано

1

Theoretical Framework and Emerging Challenges of Lipid Metabolism in Cancer DOI Creative Commons
Qiuying Gu, Yuan Wang, Ping Yi

и другие.

Seminars in Cancer Biology, Год журнала: 2024, Номер unknown

Опубликована: Дек. 1, 2024

Elevated lipid metabolism is one of hallmarks malignant tumors. Lipids not only serve as essential structural components biological membranes but also provide energy and substrates for the proliferation cancer cells tumor growth. Cancer meet their needs by coordinating processes absorption, synthesis, transport, storage, catabolism. As research in this area continues to deepen, numerous new discoveries have emerged, making it crucial scientists stay informed about developments metabolism. In review, we first discuss relevant concepts theories or assumptions that help us understand -based therapies. We then systematically summarize latest advancements including mechanisms, novel targets, up-to-date pre-clinical clinical investigations anti-cancer treatment with targeted drugs. Finally, emphasize emerging directions therapeutic strategies, future prospective challenges. This review aims insights guidance field

Язык: Английский

Процитировано

8

Functional heterogeneity of fibroblasts in primary tumors and metastases DOI Creative Commons
Priscilla S.W. Cheng, Marta Zaccaria, Giulia Biffi

и другие.

Trends in cancer, Год журнала: 2024, Номер unknown

Опубликована: Дек. 1, 2024

Язык: Английский

Процитировано

8

Association between cancer-associated fibroblasts and prognosis of neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma: a bioinformatics analysis based on single-cell RNA sequencing DOI Creative Commons
Zhao Huang,

Zhuang‐Zhuang Cong,

Jing Luo

и другие.

Cancer Cell International, Год журнала: 2025, Номер 25(1)

Опубликована: Март 1, 2025

Esophageal squamous cell carcinoma (ESCC) is a prevalent and aggressive subtype of esophageal cancer, posing significant mortality economic burden, especially in East Southeast Asia. Current therapeutic strategies have limitations improving patient survival, particularly regarding disease progression resistance. This study aimed to investigate the impact neoadjuvant chemoradiotherapy (NCRT) on ESCC microenvironment. We utilized single-cell RNA sequencing systematically characterize tumor cancer-associated fibroblasts (CAFs) subtypes. Marker genes myofibroblastic CAFs (myCAFs) were employed establish prognostic model verify its application other datasets. Other experiments conducted clinical samples explore potential risk-related genes. Our bioinformatics statistical analyses revealed an increased proportion epithelial cells NCRT identified Ep_c1 associated with better prognosis. Further results indicated complex communication network between myCAFs. The top 30 marker myCAFs used construct signature response immunotherapy. Finally, Complement C1s subcomponent (C1S), Decorin (DCN), Neuroblastoma suppression tumorigenicity 1 (NBL1) as findings highlight dynamic alterations post-NCRT microenvironment provide foundation for development personalized treatment immunotherapeutic approaches. Future studies are warranted further validate these their implications.

Язык: Английский

Процитировано

1